Healthcare provider profile · identity verified

Zinta Zarins

Family Practice · FONTANA, CA · NPI 1255743167

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	454	180
Amlodipine Besylate	Amlodipine Besylate	237	89
Levothyroxine Sodium	Levothyroxine Sodium	227	78
Losartan Potassium	Losartan Potassium	224	77
Lisinopril	Lisinopril	215	87
Rosuvastatin Calcium	Rosuvastatin Calcium	183	80
Metformin Hcl Er	Metformin Hcl	145	57
Omeprazole	Omeprazole	142	58
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	129	29
Albuterol Sulfate Hfa	Albuterol Sulfate	126	69
Atenolol	Atenolol	113	37
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	113	43
Alendronate Sodium	Alendronate Sodium	104	39
Potassium Chloride	Potassium Chloride	93	38
Metoprolol Tartrate	Metoprolol Tartrate	91	32
Simvastatin	Simvastatin	89	35
Trazodone Hcl	Trazodone Hcl	88	34
Ozempic	Semaglutide	79	16
Hydrochlorothiazide	Hydrochlorothiazide	78	26
Jardiance	Empagliflozin	77	29
Glipizide	Glipizide	74	27
Gabapentin	Gabapentin	71	29
Pantoprazole Sodium	Pantoprazole Sodium	71	25
Sertraline Hcl	Sertraline Hcl	70	31
Metformin Hcl	Metformin Hcl	65	25
Ibuprofen	Ibuprofen	61	31
Azelastine Hcl	Azelastine Hcl	59	26
Meloxicam	Meloxicam	57	24
Wixela Inhub	Fluticasone Propion/Salmeterol	57	19
Prednisone	Prednisone	49	46
Bisoprolol Fumarate	Bisoprolol Fumarate	47	15
Cephalexin	Cephalexin	47	46
Pradaxa	Dabigatran Etexilate Mesylate	43	16
Acyclovir	Acyclovir	40	14
Furosemide	Furosemide	40	19
Montelukast Sodium	Montelukast Sodium	35	14
Ezetimibe	Ezetimibe	33	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	28
Ofloxacin	Ofloxacin	31	31
Lovastatin	Lovastatin	30	suppressed
Alvesco	Ciclesonide	29	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	13
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	29	12
Ondansetron Odt	Ondansetron	29	11
Terazosin Hcl	Terazosin Hcl	29	14
Duloxetine Hcl	Duloxetine Hcl	27	14
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Mupirocin	Mupirocin	27	18
Allopurinol	Allopurinol	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	15
Spironolactone	Spironolactone	26	14
Azithromycin	Azithromycin	22	22
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	21	12
Lorazepam	Lorazepam	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Victoza 2-Pak	Liraglutide	20	suppressed
Finasteride	Finasteride	19	suppressed
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	18	18
Carvedilol	Carvedilol	18	suppressed
Colchicine	Colchicine	18	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	18	suppressed
Humulin N	Insulin Nph Human Isophane	18	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	18	suppressed
Lidocaine	Lidocaine	18	suppressed
Clopidogrel	Clopidogrel Bisulfate	17	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	17
Famotidine	Famotidine	17	suppressed
Tramadol Hcl	Tramadol Hcl	17	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	17	suppressed
Hydrocortisone	Hydrocortisone	16	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	15	15
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	15	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	15	suppressed
Fluconazole	Fluconazole	15	14
Fluticasone Propionate	Fluticasone Propionate	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Estradiol	Estradiol	14	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	11
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Naproxen	Naproxen	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	12
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Nystatin	Nystatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error